Chargement en cours...
Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse
This case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse...
Enregistré dans:
| Publié dans: | Case Rep Psychiatry |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952553/ https://ncbi.nlm.nih.gov/pubmed/29854531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9864285 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|